No profile data available.
Marksans Pharma Limited (MARKSANS.NS) is a healthcare company in the brain and nerve treatment drugs industry, based in Mumbai, India, with about 1,685 full-time employees.
In Q3 2026 (the quarter ended December 31, 2025) revenue was 7.54 billion INR, up 10.6% from a year before. United States and North America was its largest region in fiscal year 2025, with 47% of revenue. Its market capitalization was 140.07 billion INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.
United States and North America: 47% of revenue by region in fiscal year 2025, followed by Europe and The United Kingdom (39%).
140.07 billion INR as of October 9, 2026.